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Background: A retrospective cohort study was conducted to determine the situation, trend, and factors associated
with TB infection, and factors related to the life status among the HIV/AIDS Hill-tribe in Northern Thailand. Hill-tribe
people have been migrating to and formed settlements along the Thai border areas for many decades. There are
now having 1.6 million people of 6 different groups–Akha, Lahu, Lisu, Hmong, Yao and Keren–each with a specific
culture, language and lifestyle. The Hill-tribe becomes a new vulnerable of HIV and TB infections in Thailand.
Methods: A systematic data-reviewing approach was used to identify the information from the rosters of ARV
clinics, OPD cards, and laboratory reports from 16 hospitals in Chiang Rai Province, Thailand. The data were
collected from the first reported HIV/AIDS case of the Hill-tribe to the end of 2010. A chi-square test and logistic
regression models were used to identify associations at the significance level of alpha = 0.05.
Results: A total of 3,130 cases were included in the study. The majority of patients were Akha (46.0 %) followed by
Lahu (19.7 %), 54.6 % were males, 44.6 % were 26–35 years old. The major risk factor of HIV infection was sexual
intercourse (93.1 %); 23.9 % were still alive at the date of data collection, 30.7 % were diagnosed with pulmonary
TB. The Akha Hill-tribe HIV/AIDS individuals had a greater chance of TB infection than did Yao individuals with
ORadj = 1.50 (95 % CI = 1.01-1.92). Females had a greater chance of TB infection than males with ORadj = 1.33
(95 % CI = 1.11-1.59); being classified as HIV and AIDS groups had a greater chance of TB infection than those
asymptomatic group with ORadj = 11.59 (95 % CI = 7.19-18.71), and ORadj = 1.71 (95 % CI = 1.03-2.87); and not having
received the ARV group had a greater chance of TB infection than those who having received the ARV group with
ORadj = 2.59 (95 % CI = 2.09-3.22). The patients who had been diagnosed with HIV infection during 1990–1995 and
1996–2000 had less chance of TB infection than those who were diagnosed from 2006–2010, with ORadj = 0.04
(95 % CI = 0.01-0.14) and 0.11 (95 % CI = 0.07-0.17), respectively. Regarding life status; females had a better chance
of being still alive at the date of data collection than being males with ORadj = 1.41 (95 % CI = 1.19-1.66). Those who
had a defined route of transmission in the category of “mother-to-child” and “IDU” had a better chance of being
still alive compared to those who contracted HIV from “sexual intercourse,” with ORadj = 2.05 (95 % CI = 1.56-2.18),
and ORadj = 8.45 (95 % CI = 1.55-46.13), respectively.
Conclusions: Thailand needs to create a TB and HIV/AIDS surveillance system for Hill-tribe populations to
determine the situation and trend and to develop an appropriate model for providing care at the earlier stage of
HIV/AIDS infection to prevent later TB infection.
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Background
The Millennium Development Goals (MDGs) has set
eight goals for the most pressing development chal-
lenges, with a set of measurable time-bound targets. The
sixth goal is “…. having halted by 2015 and begun to re-
verse the incidence of major serious infectious diseases
such as the Human Immunodeficiency Virus (HIV) In-
fection, and Tuberculosis (TB).” Tuberculosis control
targets are to halt and begin to reverse the rising inci-
dence of TB and to halve the 1990 prevalence and death
rates by 2015, and 22 million lives worldwide have been
saved from tuberculosis since 1995 [1].
HIV/AIDS is still a major global health problem, hav-
ing claimed more than 39 million lives since the first
HIV case report; the great majority of sufferers live in
developing countries, particularly Africa and Asia. Glo-
bally, by the end of 2013, 1.5 million people had died
from HIV-related causes, and approximately 35.0 million
people were living with HIV, with 2.1 million being
newly detected cases [2].
Tuberculosis is a communicable bacterial infection
that is second only to HIV/AIDS as the greatest killer
worldwide due to a single infectious agent. TB is also
the most significant opportunistic infection among AIDS
patients, causing one fourth of all HIV-related deaths
worldwide. In 2013, nine million people had tubercu-
losis, of which 1.5 million died, representing a decrease
in TB mortality of 45.0 % between 1990 and 2013 [3]
due to the effort of innumerable health-related agencies
striving to reach the MDG target of an 85.0 % reduction
of TB incidence worldwide. In fact, the goal had been
exceeded for the fourth consecutive year [1]. Still, more
than 95.0 % of tuberculosis deaths occur in low-and
middle-income countries.
The population of Thailand reached 67,222,972 in
October 2014 [4]. Due to the development of economics,
medical sciences, and public health services, Thai life
expectancy has increased to 73.6 years on average,
71.3 years for males and 76.1 years for females [4]. How-
ever, it is widely accepted that AIDS has reached an epi-
demic proportion in Thailand particularly in northern
and middle regions. Approximately 2.0 % of males and
1.5 % of females live with HIV/AIDS, while the figure
was 0.8 % globally in 2011 [5]. Since the first AIDS case
was reported in Thailand in 1984, there have been
388,621 cumulative cases of HIV/AIDS, and 100,617
have died [6]. Tuberculosis is the highest occurring
(29.5 %) opportunistic infection among HIV/AIDS in
Thailand [6].
In 2013, there were an estimated 1.1 million TB-HIV
co-infections globally, 78.0 % in sub-Saharan Africa. TB
is the leading cause of death among people living with
HIV, accounting for some 360,000 people who die of
HIV-associated TB annually, with no difference between
males and females [7]. Approximately one-third of
people living with HIV/AIDS worldwide have latent tu-
berculosis, and these individuals are at a 29 times greater
risk of developing active TB disease than those without
HIV. These individuals are also at a greater risk of con-
tracting drug-resistant TB, of which a delay in diagnosis
increases mortality [7].
Thailand is one of the 22 countries with a high bur-
den of both TB as identified by the World Health
Organization [8]. In 2011, the HIV/AIDS co-infection
prevalence in Thailand was 161/100,00 [8]. Risky be-
haviors and insufficient knowledge about HIV remain
at alarmingly high levels among the sexually active
age group in marginalized populations, such as the
Hill-tribe people in Thailand.
Thailand has computerized population database as all
Thais are required by law to register for an Identification
(ID) card by age 7. A Thai ID card with ID number is es-
sential for most legal or formal transactions in Thailand
including claiming access to government free or subsi-
dized health service. Hill-tribe people have been migrat-
ing to and formed settlements along the Thai border
areas for many decades (Fig. 1). They are now living in
different locations in Chiang Rai Province, Thailand
(Fig. 2). Their settlements are gradually becoming more
permanent with later generations but there is still a trad-
ition of Hill-tribe people crisscrossing the border ac-
cording to their economic, cultural or political necessity
from time to time. Their villages are often in very re-
mote areas making applying for a house registration or
address either difficult or unnecessary. Their status is
rather like one of an alien refugee even well into a sec-
ond or third generation of immigrants. Successive Thai
governments, being concerned about border security,
have taken a cautious approach toward conferring Thai
citizenship to Hill-tribe people by granting different
types and stages of internal passport and citizenship.
Many still have not obtained documentation which enti-
tles them to travel legally within an allowed area due to
lack of information, language barrier, fear of arrest etc.,
which considerably restricts their movement including
seeking employment, education for children, and med-
ical treatment. Also traditional belief and medical system
is still strong in their villages and which many may
choose to manage their health and illnesses.
Hill-tribes in Thailand are classified into six main
groups [9]: Lahu, Akha, Lisu, Karen, Yao and Kmong.
These tribes have immigrated from the south of China
to Thailand in the last several decades. Approximately
1,600,000 tribe people were living in Thailand in 2013
[9]. Each group has their own language, culture and be-
liefs, which are different from those of the Thai. Most
live in the mountainous border areas in north of
Thailand among 16 provinces. The Hill-tribe people of
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Chiang Rai Province, the northernmost province of
Thailand, live in 652 villages with a total population of
180,214 persons [10]. Their villages are in remote areas
approximately 70 km from the capital city with poor
road access and public transport. Many Hill-tribe people
do not qualify for or have failed to obtain a Thai identifi-
cation card, which generally is required for free or subsi-
dized government medical and educational services.
Most of the Hill-tribe people, if working, work in man-
ual jobs with low pay. The Hill-tribe people in northern
Thailand therefore still have limited opportunity to earn
money, receive health information, and have access to
affordable healthcare. These populations are vulnerable
to infectious diseases, such as HIV and TB.
There is no information regarding the TB and
HIV/AIDS status among the Hill-tribes of Thailand.
Through a systematic review of the secondary infor-
mation from 16 hospitals in Chiang Rai Province,
this study aimed to determine the situation, trend,
and factors associated with TB among the Hill-tribe
HIV/AIDS population who had received care from




A retrospective cohort study was conducted to investi-
gate the situation, trend, and factors associated with TB
Fig. 1 Hill-tribe migratory map in Thailand. Mien and Hmong had the same migratory route from the south of China through the Republic of
Laos to northern Thailand. Akha, Lahu and Lisu had the same migratory route from the south of China through the Republic of Laos to Northern
Thailand. Karen had migrated into western region of Thailand. The figure is adapted from http://www.hilltribe.org/thai/museum/. The figure’s
holder is The Mirror Foundation, Thailand, and has been premised to use by the director of The Mirror Foundation, Thailand
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infection among Hill-tribe HIV/AIDS patients who had
visited one of the 16 hospitals in Chiang Rai Province,
Thailand, from the first reported HIV case (who was a
Hill-tribe patient) until 2010.
Study population
The study population constituted Hill-tribe patients who
were living in one of the 652 Hill-tribe villages in Chiang
Rai Province. These villages were made up of 36 Karen
(7,628 persons), 59 Kmong (31,522 persons), 63 Yao
(13,400 persons), 243 Akha (68,897 persons), 216 Lahu
(48,835 persons), and 35 Lisu (9,932 persons) villages,
with in total 180,214 persons.
Study sites and source of data
Patients’ information were collected from the records of
ARV clinics of the 16 hospitals in Chiang Rai Province,
which were Chiang Rai Central, Wiang Pa Pao, Mae Chan,
Wiang Ken, Chiang Saen, Mae Suai, Mae Fah Laung,
Phaya Mengrai, Doi Luang, Phan, Chiang Khong, Wiang
Chai, Thoeng, Khun Tan, Mae Sai, and Mae Lao hospitals.
The author was granted permission to assess hospital re-
cords for analysis from the hospital director, and was
granted to access data in the step of subjects’ identification
from the chief of the district government office.
In this study, four data sources were used to complete
the information: a) a government database to identify
the tribe of the subjects; b) ARV rosters to collect gen-
eral information, including history of TB infection; c) la-
boratory reports to support laboratory information; and
d) OPD card for a complete medical record, including
history of treatments and OI infections.
Eligible population
The eligible population of the study was Hill-tribe pa-
tients who were living in Chiang Rai and had a diagnosis
Fig. 2 Different destination sites of the Hill-tribe in Chiang Rai Province, Thailand. Most of Akha, Yao, and Lahu have settled throughout Chiang
Rai Province. Hmong has settled in eastern of Chiang Rai Province. Karen and Lisu have settled in the western of Chiang Rai Province
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of HIV/AIDS who had visited one of the 16 hospitals
during the period from when the first Hill-tribe
HIV/AIDS patient was reported to the hospital sys-
tem in 2010.
Inclusion criteria
The inclusion criteria included patients whose medical
records indicated that they were a) identified as Hill-tribe
persons, b) living in the study areas, and c) medically diag-
nosed as having HIV/AIDS with or with out tuberculosis.
Sample size
All of the HIV/AIDS patients in the rosters of 16
ARV clinics from the first case of HIV/AIDS in the t-tribe
through 2010 were included in the study. TB diagnosis
was made by a combination of clinical, radiological and
laboratory methods based on the date of diagnosis.
HIV/AIDS classification was done based on at the
date of diagnosis.
Research instruments
To gather and integrate information from hospital OPD
cards and ARV clinic records, we developed a data col-
lection form with three parts: a) basic information part
for patient characteristics, such as age, sex, tribe, marital
status, weight, height, drug use history, etc.; b) labora-
tory information, such as the CD4 level, viral load, CBC,
sputum test, etc.; and c) clinical information, such as
history, symptoms, signs, treatment, and health status
(alive or dead) at the last record entry. The form was
validated by Content Validity Index (CVI) method before
use. TB and HIV/AIDS diagnosis was used.
Data-gathering procedures
The collecting information form was developed after the
literature review. The form was validated by three exter-
nal experts in the field of TB-HIV/AIDS; one worked at
School of Health Science, and another two worked at
the Ministry of Public Health, Thailand, and piloted in a
study at Mae Chan Hospital. The systematic reviewing
process was tested in Mae Chan Hospital before com-
mencing the project.
Written permission for access information was granted
by the director of each hospital and the chief of each
ARV clinic. The information from each unit (ARV, OPD,
and Laboratory) was linked by the hospital number. Be-
fore reviewing and investigating the information in any
section of the hospital, the ARV staff helped to identify
the cases that met the inclusion criteria.
In the verification process of the Hill-tribe people, we
first used the database of the district government office
system to identify the residential location of the patients,
including village and patient’s names, and second, the in-
formation from the ARV was used to confirm verification
process to ensure that all of the subjects that were in-
cluded in the study met the inclusion and exclusion
criteria.
Statistical analysis
The data were double-entered by two different persons
and validated using Microsoft Excel. A data analysis was
carried out using STATA version 8.2 (Stata Corp, College
Station, TX), and Epi-Info version 6.04d (US Centers for
Disease Control and Prevention, Atlanta, GA).
Both descriptive and inferential statistics were used to
analyze the information. For a descriptive analysis, the
mean, standard deviation, minimum, and maximum
were used to describe the characteristic of continuous
variables, while the percentage or proportion was used
to describe the characteristic of categorical variables.
A chi-square test and logistic regression were used to
detect the association between independent and dependent
variables at critical values of 0.10 in the univariate model
and 0.05 in the multivariate model.
Ethical consideration
This research study was approved by The Ethics in
Human Research Committee of Mae Fah Luang
University. Permission to collect data in nine hospitals
in Chiang Rai Province was granted by The Chiang Rai
Provincial Public Health Office. Patient records and in-
formation was anonymized and re-identified prior to
analysis.
Results
There were 3,130 Hill-tribe HIV/AIDS patients from 16
hospitals in Chaing Rai Province between 1990 and 2010
who were recuited for the study based on the criteria. Of
these cases, 960 (30.7 %) had at least one episode of TB.
The first case of HIV/AIDS in the Hill-tribe people was
a 25-year-old Lisu, reported at Mae Suai Hospital,
Chiang Rai Province, in 1990.
The majority of the tribes were Akha (46.0 %),
followed by Lahu (19.7 %) and Yao (9.5 %). More than
half were male (54.6 %), and 44.6 % were 26–35 years
old, followed by 36–45 years old (25.2 %), and 16–25
years old (14.3 %). The peak period of HIV/AIDS infec-
tion among the Hill-tribes occurred from 2001–2005
(43.9 %), followed by 2006–2010 (33.7 %).
Regarding the habitat, 25.8 % of the people resided in
the Mae Fah Laung district, followed by 18.8 % in the
Mae Suai district, 16.2 % in the Muang Chiang Rai dis-
trict, and 11.1 % in Mae Chan district. Regarding the oc-
cupations, 44.8 % were agricultural workers and 32.2 %
were daily and temporary employees. The major risk
factors of HIV infection were sexual intercourse
(93.1 %), 6.4 % mother-to-child, and 0.5 % IDU. Most of
the subjects did not recive ARV (66.7 %), only 297 had a
Apidechkul BMC Infectious Diseases  (2016) 16:72 Page 5 of 14
measured CD4 level, 23.9 % were still alive at the date of
data collection, and 30.7 % had TB disease documented
at some time after the HIV/AIDS infection was diag-
nosed (Table 1).
Table 2 shows the proportion of TB-positive and-
negative cases in various factors; eight variables had a
statistically significant difference – tribal groups, risk
factors, survival status, sex, age, occupation, diagnosis,
and receiving ARV at a significance level of 0.50. Regard-
ing the tribes, 33.7 % of Akha-HIV and 32.6 % of Lahu-
HIV had at least one episode of TB, which was greater
than the other tribes. Female-HIV group had a greater
proportion of TB disease (34.8 %) than the male-HIV
group (27.3 %). HIV/AIDS patients who worked as
trader and temporary employees groups had a 43.9 %
and 41.0 % incidence of TB disease.
Table 3 shows the eight variables that were statistically
significantly related to TB infection among the Hill-tribe
HIV/AIDS patients in the simple logistic regression
model at a significance level of 0.10. The Lisu and Akha
groups had a greater chance of TB infection – 1.40 and
1.46 times greater than that of the Yao, respectively. Be-
ing female was a factor associated with TB infection
(1.42 times compared to being male), and the Hill-tribe
HIV/AIDS patients age 26–35 and 46–55 had 1.85 and
1.92 times greater chance, respectively, of TB infection
than did those aged less than 15 years.
Mother-to-child transmission of HIV/AIDS patients
was less likely to result in TB infection among the HIV/
AIDS Hill-tribe patients compared to sexual intercourse,
with OR = 0.57 (90 % CI = 0.42-0.76). Moreover, those
who did not receive ARV presented as a greater chance
of TB infection among the HIV/AIDS Hill-tribe, with
OR = 2.76 (90 % CI = 2.38-3.31).
In the multiple logistic regression model, five vari-
ables had a statistically significant association with TB
infection among the Hill tribe HIV/AIDS individuals.
The Akha Hill-tribe HIV/AIDS individuals had a
greater chance for TB infection than did the Yao,
with ORadj = 1.50 (95 % CI = 1.01-1.92). Females had a
greater chance of TB infection than did males, with
ORadj = 1.33 (95%CI = 1.11-1.59). The HIV and AIDS
groups had a greater chance of TB infection among
the HIV/AIDS Hill-tribe people, with ORadj = 11.59
(95 % CI = 7.19-18.71) and ORadj = 1.71 (95%CI = 1.03-2.87)
compared to those in the asymptomatic group. For
the Hill-tribe HIV/AIDS individuals, not receiving
ARV was a factor associated with TB infection, with
ORadj = 2.59 (95 % CI = 2.09-3.22). Patients who had
been diagnosed with HIV infection from 1990–1995
and 1996–2000 were less likely to have TB compared
to those who were diagnosed from 1990–1995, with
ORadj = 0.04 (95 % CI = 0.01-0.14) and ORadj = 0.11
(95 % CI = 0.07-0.17), respectively (Table 4).
Table 5 shows the nine variables in the simple logistic
regression analysis that had a statistically significant as-
sociation with the patients’ life status at the date of data
collection (alive or dead from the medical record) of the
Hill-tribe HIV/AIDS individuals. The Karen and Kmong
had less chance of being still alive at the date of data
collection compared to the Yao tribe, with OR = 0.58
(90 % CI = 0.43-0.77) and OR = 0.55 (90 % CI = 0.41-
0.74), respectively. Patients aged 16 years and above had
less chance of being still alive compared to those aged
less than 15 years, with OR = 0.51 (90 % CI = 0.37-0.69),
OR = 0.60 (90 % CI = 0.46-0.79), OR = 0.60 (90 % CI =
0.45-0.80), and OR = 0.33 (90 % CI = 0.20-0.53) respect-
ively. Those who had been diagnosed with HIV and
AIDS had less chance of being still alive compare to
those asymptomatic group, with OR = 0.06 (95 % CI =
0.04-0.12), and OR = 0.25 (90 % CI = 0.10-0.47) re-
spectively. Those who had been infected through
mother-to-child transmission and IDU had a better
chance of being still alive at the date of data collection,
with OR = 2.05 (90 % CI = 1.56-2.68) and OR = 8.45 (90 %
CI = 1.55-46.13), respectively. Patients who did not receive
ARV had less chance of being still alive at the date of data
collection than those who received ARV, with OR = 0.15 (
90 % CI = 0.12-0.19), and those who had an occupation in
the categories of “temporary employee,” “housewife,” “stu-
dents”, and “others” had a better chance of being still alive
at the date of data collection compared to “agriculture,”
with OR = 1.88 (90 % CI = 1.66-2.19), OR = 1.61 (90 %
CI = 1.10-2.36), OR = 5.46 (90 % CI = 3.21-9.30), and
OR = 1.74 (90 % CI = 1.36-2.23), respectively. Patients
who had been diagnosed from 1990–1995, 1996–2000,
and 2001–2005 had less chance of being still alive at the
date of data collection compared with those who had been
diagnosed between 2006 and 2010, with OR = 0.03 (90 %
CI = 0.01-0.08), OR = 0.06 (90 % CI = 0.04-0.09), and
OR = 0.82 (90%CI = 0.71-0.95) respectively.
From the multiple logistic regression model at a sig-
nificance level of 0.05, five variables were statistically sig-
nificantly associated with patients’ life status at the date
of data collection. The Karen and Kmong had less
chance of being still alive compared to the Yao, with
ORadj = 0.58 (95 % CI = 0.43-0.77), and ORadj = 0.55
(95 % CI = 0.41-0.74), respectively. Females had a better
chance of being still alive than males, with ORadj = 1.41
(95 % CI = 1.19-1.66). Patients who were diagnosed with
“HIV” and “AIDS” had less chance of being still alive
than those who were diagnosed with “Asymptomatic,”
with ORadj = 0.05 (95 % CI = 0.03-0.09), and ORadj = 0.34
(95 % CI = 0.17-0.64), respectively. Those who had a de-
fined route of transmission in the category of “mother-
to-child” and “IDU” had a better chance of being still
alive compared to those who contracted HIV from “sex-
ual intercourse,” with ORadj = 2.05 (95 % CI = 1.56-2.68)
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and ORadj = 8.45 (95 % CI = 1.55-46.13), respectively. Fi-
nally, patients who did not receive ARV had less chance
of being still alive compared to those who received ARV,
with ORadj = 0.11 (95 % CI = 0.08-0.14) (Table 6).
Discussion
Our study illustrates that among 3,130 members of the
Hill-tribe HIV/AIDS population, major factors associ-
ated with TB infection were being from the Akha tribe,
being female, HIV and AIDS stages, and non-receiving
ARV compared to the others tribes, being male, asymp-
tomatic stage, and receiving ARV, respectively. Regard-
ing factors related to patients’ survival status, we found
that being of the Karen and Kmong tribes, non-receiving
ARV, and HIV and AIDS stages had less of an oppor-
tunity to survive compare to those of being from
other tribes, receiving ARV, and asymptomatic stage,
respectively.




















Max = 90, Min = 0, Mean = 31.83
Occupation
Agriculture 1,403 44.8
Temporary employee 1,007 32.2
Trader 57 1.8
Housewife 98 3.1
Children (<7 years) 109 3.5









Muang Chiang Rai 507 16.2
Wiang Pa Pao 442 14.1
Mae Chan 348 11.1
Wiang Ken 123 3.9
Chiang Saen 41 1.3
Mae Suai 589 18.8
Mae Fah Laung 808 25.8
Phaya Menrai 28 0.9
Doi Luang 40 1.3
Phan 73 2.3
Table 1 General characteristics of the hill tribe HIV/AIDS
(Continued)
Chiang Khong 58 1.9
Wiang Chai 18 0.6
Thoeng 14 0.5
Khun Tan 2 0.1
Mae Sai 14 0.5
Mae Lao 25 0.8
Diagnosis as (classified in medical record)
Asymptomatic 373 11.9
HIV (AIDS related complex) 2,060 65.8
AIDS 697 22.3
Route of transmission
Sexual intercourse 2,913 93.1
Mother to child 200 6.4
IDU 17 0.5
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This study has a major limitation in the quality of the
available secondary data. The identification and confirm-
ation of a patient’s Hill-tribe status was a significant
challenge. Fortunately, in identifying which patient on
the hospital lists was a Hill-tribe person, we could rely
on the characteristics of their first and last names, which
provide a reliable clue to whether they met the inclusion
criteria. The naming tradition is that the child takes the
father’s last name (which is recorded on the hospital
registration) even if he/she has grown up and chosen
later to belong to a different tribe than that of his/her
parents. The local ARV clinic staff had been extremely
helpful in this respect, as most of them have worked in
the area for many years and know the patients, their
families and their villages intimately from providing
counseling and health checks and giving out medication
on a monthly basis. A few subjects had changed their
first name, but it was not a problem for classification be-
cause most still lived in their original village. Missing of
the specific date of last visited among the subjects, as a
result could not use a better statistical model such as
survival analysis including hazard model.
Prior to 2000, the majority of the Hill-tribe people did
not have Thai identification cards, which is one reason
for the poor attendance to clinics of this section of the
study population during this period. Another important
reason is that, for several years after HIV/AIDS diagno-
sis became recognized, the condition did not entitle the
person to free medical care under the government’s uni-
versal medical care scheme. It is certain that many suf-
ferers had never been diagnosed or that if they had been
initially, they became lost to follow up due to financial
constraints for treatment. The overall result of this study
is that the recorded number of HIV patients who we
were able to trace from records must have been lower
than the true number in the beginning of the survey
periods.
Other reasons that affected the number of recorded
cases included social stigmatization in the early days,
which deterred patients from seeking hospital care. Api-
dechkul in 2009 found that Akha youths, members of
one of the Hill-tribes, preferred to travel to large cities
to seek employment to support their families, and some
contracted HIV/AIDS during their time away from
home [11].
Previously available information from the Chiang Rai
Public Health Office reported that between 1987 and
2009, the highest number of TB cases of HIV/AIDS in
the province was recorded [12], 44.0 % of which were
smear-positive pulmonary TB; among the TB infection
patients, 24.0 % tested positive for HIV/AIDS. The Thai
Public Health aimed at a TB treatment success rate of
85 %, but the actual success rate was 73.2 %, while it
was only 64.7 % in those with HIV. Those who lived in
Table 2 Comparison between TB-HIV and non TB-HIV patients
Characteristics TB χ2-test p-value
No (%) Yes (%)
Tribal group
Akha 955 (66.3) 486 (33.7) 15.780 0.008*
Karen 200 (73.8) 71 (26.2)
Kmong 157 (71.0) 64 (29.0)
Lahu 447 (72.4) 170 (27.6)
Lisu 190 (67.4) 92 (32.6)
Yao 221 (74.2) 77 (25.8)
Route of transmission
Sexual intercourse 1,975 (68.9) 893 (31.1) 7.727 0.026*
Mother to child 185 (75.8) 59 (24.2)
IDU 9 (52.9) 8 (47.1)
Survival status
Alive 859 (82.4) 184 (17.6) 124.888 <0.001*
Dead 1,311(62.8) 776 (37.2)
Sex
Male 1,244 (72.7) 466 (27.3) 20.727 <0.001*
Female 926 (65.2) 494 (34.8)
Age (year)
<15 184 (80.0) 46 (20.0) 51.263 <0.001*
16-25 345 (77.0) 103 (23.0)
26-35 955 (68.4) 441 (31.6)
36-45 494 (62.5) 296 (37.5)
46-55 133 (67.5) 64 (32.5)
>56 59 (85.5) 10 (14.5)
Occupation
Agriculture 1,067(76.1) 336 (23.9) 106.869 <0.001*
Temporary employee 594 (59.7) 413 (41.0)
Trader 32 (56.1) 25 (43.9)
Housewife 79 (80.6) 19 (19.4)
Children (<7 years) 93 (85.3) 16 (14.7)
Students (7 > University) 73 (70.2) 31 (29.8)
Unemployed 62 (69.7) 27 (30.3)
Others 170 (64.6) 94 (35.4)
Diagnosis
Asymptomatic 353 (94.6) 20 (5.4) 298.643 <0.001*
HIV 1,220 (59.2) 840 (40.8)
AIDS 597 (85.7) 100 (14.3)
ARV
Yes 1,312 (62.8) 776 (37.2) 124.384 <0.001
No 858 (82.3) 184 (17.7)
*Significance level at p-value < 0.05
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Table 3 Simple logistic regression of the factors associated with of TB disease among the hill tribe HIV/AIDS
Factors TB OR (90 % CI) p-value
No (%) Yes (%)
Tribal group
Akha 955 (66.3) 486 (33.7) 1.46 (1.15-1.85) 0.008*
Karen 200 (73.8) 71 (26.2) 1.02 (0.74-1.39) 0.922
Kmong 157 (71.0) 64 (29.0) 1.17 (0.84-1.62) 0.430
Lahu 447 (72.4) 170 (27.6) 1.10 (0.84-1.42) 0.584
Lisu 190 (67.4) 92 (32.6) 1.40 (1.03-1.87) 0.050*
Yao 221 (74.2) 77 (25.8) 1.00
Sex
Male 1,244 (72.7) 466 (27.3) 1.00
Female 926 (65.2) 494 (34.8) 1.42 (1.25-1.62) <0.001*
Age (year)
<15 184 (80.0) 46 (20.0) 1.00
16-25 345 (77.0) 103 (23.0) 1.19 (0.86-1.66) 0.374
26-35 955 (68.4) 441 (31.6) 1.85 (1.39-2.46) <0.001*
36-45 494 (62.5) 296 (37.5) 2.40 (1.78-3.23) <0.001*
46-55 133 (67.5) 64 (32.5) 1.92 (1.33-2.78) 0.004*
>56 59 (85.5) 10 (14.5) 0.67 (0.36-1.26) 0.306
Year of diagnosis
1990-1995 151 (98.1) 3 (1.9) 0.035 (0.01-0.09) <0.001*
1996-2000 524 (95.6) 24 (4.4) 0.081 (0.06-0.12) 0.041*
2001-2005 823 (59.9) 551 (40.1) 1.18 (1.03-1.35) 0.053*
2006-2010 672 (63.8) 382 (36.2) 1.00
Occupation
Agriculture 1,067 (76.1) 336 (23.9) 1.00
Temporary employee 594 (59.0) 413 (41.0) 2.21 (1.91-2.56) <0.001*
Trader 32 (56.1) 25 (43.9) 2.48 (1.58-3.89) 0.001*
Housewife 79 (80.6) 19 (19.4) 0.76 (0.49-1.17) 0.306
Children 93 (85.3) 16 (14.7) 0.55 (0.35-0.86) 0.030*
Student 73 (70.2) 31 (29.8) 1.35 (0.93-1.95) 0.181
Unemployed 62 (69.7) 27 (30.3) 1.38 (0.93-2.05) 0.175
Others 170 (64.4) 94 (35.4) 1.74 (1.37-2.19) <0.001*
Diagnosis
Asymptomatic 353 (94.6) 20 (5.4) 1.00
HIV 1,220 (85.7) 840 (40.8) 12.15 (8.27-17. 86) <0.001*
AIDS 597 (85.7) 100 (14.3) 2.95 (1.95-4.49) <0.001*
Route of transmission
Sexual intercourse 1,976 (68.9) 893 (31.1) 1.00
Mother to Child 185 (75.8) 59 (24.2) 0.57 (0.42-0.76) 0.002*
IDU 9 (52.9) 8 (47.1) 1.96 (0.88-4.36) 0.170
ARV
No 858 (82.3) 184 (17.7) 2.76 (2.37-3.31) <0.001*
Yes 1,312 (62.8) 776 (37.2) 1.00
*Significance level at p-value < 0.10
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remote areas had a greater default rate than those who
lived near health centers [12], and default during TB
treatment was a significant problem in HIV-infected pa-
tients [13]. Apidechkul in 2012 [14] reported that most
of the TB infections in the Hill-tribe population, at
84.6 %, were pulmonary TB, and only 22.7 % were cured,
while the HIV/AIDS prevalence among the Hill-tribe TB
patients was 17.2 %. This report supports the results of
the study that the Chain Rai province has a high preva-
lence of TB, particularly in HIV/AIDS patients.
Due to heavy stigmatization in the early period of HIV
epidemic in Thailand, HIV with TB among the Hill-
tribes would have been under-reported during the time.
Amarita [15] reported that the confluence of the two ep-
idemics rendered TB symbolic and symptomatic of HIV
and enhanced the visibility of AIDS. Dual illness thus in-
troduced a paradox to patients’ identity constructions
and produced a unique, overlapping double stigma.
A study of Jimenez et al. (2006) found that men were
more likely to get TB infection than women in southern
Mexico [16]. However, the reports of Thorson et al.
(2001), Young et al. (2009) and Holmes et al. (1998)
found that women and girls were more likely to get TB
and more serious outcomes because of delay in diagnosis
[17–19].
Vermund et al. [20] reported that Southeast Asia faced
the problem of TB-HIV/AIDS co-infection, particularly
among MSM and IDU. However, in this study, the au-
thor found that the main route of transmission was sex-
ual intercourse. Julien Zwang et al. [21] reported that
the factors supporting the TB epidemic in Southeast
Asia were poverty, living in crowded areas, and the qual-
ity and quantity of health care services and educational
systems.
The number of TB reported cases increased steadily
from 1990 to 2010, possibly due to inaccessibility of
health care service and lack of awareness and technolo-
gies for diagnosis, and the policy of the Thai government
of identifying new TB patients based on WHO guide-
lines [22]. The study also showed that youth (≤15 years
old) had a smaller proportion of TB disease compared to
those who ≥ 16. This might reflect the limited diagnostic
options and that the numbers of HIV/AIDS patients in
this group was less than in the others.
Kingkaew et al. [23] found that those with HIV/AIDS,
especially males, were at greater risk for extrapulmonary
TB; also in HIV patients, TB meningitis and low CD4
levels were risk factors for death. This result is inconsist-
ent with our study, which found that the group without
a diagnosis of TB had a greater chance of death com-
pared to those with TB diagnosis. This paradox is most
likely explained by the limited access to treatment of a
marginalized population due to financial, social and/or
legal problems, especially during the early period of
HIV/AIDS. Mo et al. [24] also reported that patients
with multiple infections with HIV, HBV, and HCV were
at risk of developing abnormal LFTs and death during
TB treatment. Unfortunately, the documentation in our
study was not adequate for analyzing such associations.
The study also found that the Karen and Kmong tribes
had a greater chance of death than the Yao. This may be
due to their socio-economic status, which limits access
to health care and causes them to be vulnerable to dis-
ease infections [25–27]. Karen and Kmong also widely
use traditional medicine [28].
Lawn et al. [29] reported that the death rate of TB and
HIV/AIDS co-infection dramatically decreased after
scaling up HIV/AIDS testing among the TB-positive and
improved the survival of those with HIV-associated TB,
reducing mortality rates by 64 % to 95 %. This result
agrees with our study, which found that patients receiv-
ing ARV had a greater chance of surviving. Arbor et al.
[30] also reported that receiving ARV and co-trimoxazol
and having CD4 greater than 50 were supportive factors
for survival among HIV/AIDS patients. However, Boetti-
geretal et al. [31] reported that not everyone having
Table 4 Multiple logistic regression to identify the factors
associated with TB disease among the hill tribe HIV/AIDS
Factors TB ORadj (95 % CI) p-value
Yes (%) No (%)
Trible group
Akha 955 (66.3) 486 (33.7) 1.50 (1.01-1.92) 0.041*
Karen 200 (73.8) 71 (26.2) 1.11 (0.72-1.71) 0.635
Kmong 157 (71.0) 64 (29.0) 1.59 (1.01-2.53) 0.055
Lahu 447 (72.4) 170 (27.6) 0.91 (0.64-1.30) 0.619
Lisu 190 (67.4) 92 (32.6) 1.17 (0.78-1.76) 0.439
Yao 221 (74.2) 77 (25.8) 1.00
Sex
Male 1,244 (72.7) 466 (27.3) 1.00
Female 926 (65.2) 494 (34.8) 1.33 (1.11-1.59) 0.002*
Diagnosis
Asymptomatic 353 (94.6) 20 (5.4) 1.00
HIV 1,220 (59.2) 840 (40.8) 11.59 (7.19-18.71) <0.001*
AIDS 597 (85.7) 100 (14.3) 1.71 (1.03-2.87) 0.040*
ARV
No 585 (82.3) 184 (17.7) 2.59 (2.09-3.22) <0.001*
Yes 1,312 (62.8) 776 (37.2) 1.00
Year of diagnosis
1990 - 1995 151 (98.1) 3 (1.9) 0.04 (0.01-0.14) <0.001*
1996 - 2000 524 (95.6) 24 (4.4) 0.11 (0.07-0.17) <0.001*
2001 - 2005 823 (59.9) 511 (40.1) 1.39 (1.15-1.68) 0.001*
2006 - 2010 672 (63.8) 382 (36.2) 1.00
*Significance level at p-value < 0.05
Apidechkul BMC Infectious Diseases  (2016) 16:72 Page 10 of 14
Table 5 Simple logistic regression analysis of factors related to patients’ life status among the hill tribe HIV/AIDS
Factors Life status OR (90 % CI) p-value
Alive (%) Dead (%)
Tribal
Akha 343 (23.8) 1,098 (76.2) 1.02 (0.82-1.28) 0.1 36
Karen 65 (24.0) 206 (76.0) 0.58 (0.43-0.77) 0.048*
Kmong 59 (26.7) 162 (73.3) 0.55 (0.41-0.74) 0.045*
Lahu 151 (24.5) 466 (75.5) 1.05 (0.82-1.35) 0.116
Lisu 72 (25.5) 210 (74.5) 1.31 (0.97-1.77) 0.100
Yao 59 (19.8) 239 (80.2) 1.00
Sex
Male 355 (20.8) 1,355 (79.2) 1.00
Female 394 (27.7) 1,026 (72.3) 1.47 (1.28-1.68) <0.001*
Age (year)
<15 39 (17.0) 191 (83.0) 1.00
16-25 69 (15.4) 379 (84.6) 0.51 (0.37-0.69) 0.024*
26-35 341 (24.4) 1,055 (75.6) 0.60 (0.46-0.79) 0.014*
36-45 248 (31.4) 542 (68.6) 0.60 (0.45-0.80) <0.001*
46-55 50 (25.4) 147 (74.6) 0.87 (0.60-1.27) 0.074
>56 2 (2.9) 67 (97.1) 0.33 (0.20-0.53) 0.009*
Diagnosis
Asymptomatic 11 (2.9) 362 (97.1) 1.00
HIV 662 (32.1) 1,398 (67.9) 0.06 (0.04-0.12) <0.001*
AIDS 76 (10.9) 621 (89.1) 0.25 (0.10-0.47) <0.001*
TB
No 142 (6.5) 2028 (93.5) 1.00
Yes 607 (63.2) 353 (36.8) 24.56 (20.51-29.41) <0.001*
Route of transmission
Sexual intercourse 710 (24.4) 2,203 (75.6) 1.00
Mother to child 31 (15.5) 169 (84.5) 2.05 (1.56-2.68) 0.038*
IDU 8 (47.1) 9 (52.9) 8.45 (1.55-46.13) 0.003*
ARV
No 676 (32.4) 1412 (67.6) 0.15 (0.12-0.19) <0.001*
Yes 73 (7.0) 969 (93.0) 1.00
Occupation
Agriculture 282 (20.1) 1,121 (79.9) 1.00
Temporary employee 314 (31.2) 693 (68.8) 1.88 (1.66-2.19) <0.001*
Trader 17 (29.8) 40 (70.2) 0.95 (0.60-1.50) 0.078
Housewife 15 (15.3) 83 (84.7) 1.61 (1.10-2.36) 0.051*
Children (<7 years) 10 (9.2) 99 (90.8) 1.03 (0.73-1.44) 0.067
Students (7 > University) 31 (29.8) 73 (70.2) 5.46 (3.21-9.30) 0.020*
Unemployed 25 (28.1) 64 (71.9) 0.31 (0.21-0.45) 0.053
Others 5 (20.9) 208 (79.1) 1.74 (1.36-2.23) 0.047*
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ARV could control the viral load, as those patients who
had a history of opportunistic infection tended to de-
velop virological failure. A meta-analysis conducted by
Jiang et al. [32] found that ARV could be associated with
adverse events and drug interaction with antiTBs.
However, Rangaka et al. [33] suggested that isoniazid
preventive therapy should be recommended to all pa-
tients receiving antiretroviral therapy in moderate- or
high-incidence areas. Mfinanga et al. [34] suggested that
ART could be delayed until after the completion of six
months of tuberculosis treatment for HIV-positive pa-
tients with tuberculosis who have CD4 cell counts
greater than 220 cells per μL. Harries et al. [35] sup-
ported the early diagnosis and treatment of HIV infec-
tion in affected communities and proposed that the
urgent assessment of frequent testing for HIV and early
start of antiretroviral treatment (ART) should result in
short-term and long-term declines in tuberculosis inci-
dence through individual immune reconstitution and re-
duced HIV transmission. Yang et al. [36] reported that
having started HAART during TB treatment was signifi-
cantly associated with better survival. These regimens
should be considered by the Thai public health services
for implementation to improve the survival of HIV-TB
co-infection in the Hill-tribe people.
Grenfell et al. [37] reported that the latent TB infec-
tion prevalence was high and that the active disease was
more common among HIV-positive people with IDU.
However, our study found only a small proportion of
people with IDU and HIV/AIDS had TB infection
Table 6 Multivariate analysis of factors related to patients’ life status among the hill tribe HIV/AIDS
Factors Life status ORadj (95 % CI) p-value
Alive (%) Dead (%)
Tribal group
Akha 456 (31.6) 985 (68.4) 0.85 (0.82-1.28) 0.483
Karen 122 (45.0) 149 (55.0) 0.58 (0.43-0.77) 0.025*
Kmong 102 (46.2) 119 (53.8) 0.55 (0.41-0.74) 0.019*
Lahu 192 (31.1) 425 (68.9) 1.05 (0.82-1.35) 0.375
Lisu 75 (26.6) 207 (73.4) 1.30 (0.97-1.77) 0.485
Yao 96 (32.2) 202 (67.8) 1.00
Sex
Male 664 (37.7) 1,060 (62.3) 1.00
Female 399 (28.1) 1,021 (71.9) 1.41(1.19-1.66) <0.001*
Diagnosis
Asymptomatic 144 (38.6) 229 (61.4) 1.00
HIV 729 (38.4) 1,268 (61.6) 0.05 (0.03-0.09) <0.001*
AIDS 107 (15.4) 590 (84.6) 0.34 (0.17-0.64) 0.001*
Route of transmission
Sexual intercourse 992 (34.6) 1,877 (65.4) 1.00
Mother to child 50 (20.5) 194 (79.5) 2.05 (1.56-2.68) <0.001*
IDU 1 (5.9) 16 (94.1) 8.45 (1.55-46.13) 0.020*
ARV
No 676 (32.4) 1412 (67.6) 0.11 (0.08-0.14) <0.001*
Yes 73 (7.0) 969 (93.0) 1.00
*Significance level p-value < 0.05
Table 5 Simple logistic regression analysis of factors related to patients’ life status among the hill tribe HIV/AIDS (Continued)
Year of diagnosis
1990-1995 2 (1.3) 152 (98.7) 0.03 (0.01-0.08) <0.001*
1996-2000 15 (2.7) 533 (97.3) 0.06 (0.04-0.09) <0.001*
2001-2005 389 (28.3) 985 (71.7 0.82 (0.71-0.95) 0.024*
2006-2010 343 (32.5) 711 (67.5) 1.00
*Significance level p-value < 0.10
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among the Hill-tribes. The IDU is not a common route
of choice among Hill-tribe drug abusers who prefer oral
methamphetamine tablets [14].
We also found that being HIV and AIDS stages had a
greater chance for death than those an asymptomatic
stage. This is the natural history of HIV/AIDS disease in
human; those at the HIV and AIDS stages have a greater
chance of death than those at the early infection stage
[38–40].
However, early in the HIV/AIDS epidemic in Thailand,
people who knew their HIV status very often decided to
commit suicide. Therefore, HIV positive and AIDS
stages had a greater proportion of death than the asymp-
tomatic stage. This is consistent with a report by
Lotrakul [41] that the major cause of death among the
HIV/AIDS patients in Northern Thailand was suicide.
Porapakkham et al. [42], Guadamuz et al. [43],
Schlebusch et al. [44], Bundhamcharoen et al. [45],
and Chutinantakul et al. [46] also reported that sui-
cide was most prevalent in the Upper Northern
Thailand region, where HIV infection was related to
the high prevalence of suicide and was the major
cause of premature death.
The Hill-tribes of Thailand are minority groups with
specific needs due to their language, cultural and social
differences. Public health interventions to reduce the
number of new TB and HIV/AIDS cases must take such
needs into consideration in the planning and delivery of
services, especially in health education. Thomas et al.
[47] reported that using specific community-based social
and behavioral counseling, as well as voluntary testing,
could reduce the HIV incidence in Thailand and Africa.
Thato et el. [48] also reported that a brief Peer-Led HIV
Prevention Program significantly increased knowledge of
preventive behaviors and motivated participants to have
a better attitude toward preventive behaviors, better
subjective norms, and greater intention to practice pre-
ventive behavior among school children in Bangkok,
Thailand. Rojanawiwat et al. [49] reported that the
National Access to Antiretroviral Program reduced the
number of opportunistic infections, especially PCP and
TB, in Thai people living with HIV/AIDS.
Conclusion
In conclusion, the present study indicates that being
Akha and female and lacking access to ARV were the
major causes of TB infection among the HIV/AIDS
Hill-tribe population. Our study suggests an urgent
need to consistently implement TB and HIV control
programs for the Thai Hill-tribe.
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